- Home
- EUDA vs FENC Comparison
EUDA vs FENC Comparison
Compare EUDA & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- FENC
- Stock Information
- Founded
- EUDA 2021
- FENC 1996
- Country
- EUDA Singapore
- FENC United States
- Employees
- EUDA N/A
- FENC N/A
- Industry
- EUDA Blank Checks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EUDA Finance
- FENC Health Care
- Exchange
- EUDA Nasdaq
- FENC Nasdaq
- Market Cap
- EUDA 146.0M
- FENC 156.9M
- IPO Year
- EUDA N/A
- FENC 2001
- Fundamental
- Price
- EUDA $3.65
- FENC $8.12
- Analyst Decision
- EUDA
- FENC Strong Buy
- Analyst Count
- EUDA 0
- FENC 2
- Target Price
- EUDA N/A
- FENC $13.00
- AVG Volume (30 Days)
- EUDA 76.6K
- FENC 105.2K
- Earning Date
- EUDA 01-01-0001
- FENC 05-13-2025
- Dividend Yield
- EUDA N/A
- FENC N/A
- EPS Growth
- EUDA N/A
- FENC N/A
- EPS
- EUDA N/A
- FENC N/A
- Revenue
- EUDA $4,011,005.00
- FENC $30,912,000.00
- Revenue This Year
- EUDA $212.19
- FENC N/A
- Revenue Next Year
- EUDA $254.35
- FENC $58.65
- P/E Ratio
- EUDA N/A
- FENC N/A
- Revenue Growth
- EUDA 8.22
- FENC N/A
- 52 Week Low
- EUDA $2.21
- FENC $3.96
- 52 Week High
- EUDA $6.30
- FENC $8.56
- Technical
- Relative Strength Index (RSI)
- EUDA 45.83
- FENC 71.48
- Support Level
- EUDA $3.62
- FENC $7.56
- Resistance Level
- EUDA $3.80
- FENC $8.34
- Average True Range (ATR)
- EUDA 0.27
- FENC 0.47
- MACD
- EUDA -0.04
- FENC 0.10
- Stochastic Oscillator
- EUDA 32.58
- FENC 83.27
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.